2020
Duration of P2Y12 inhibitor Prescription After Percutaneous Coronary Intervention in Patients on Oral Anticoagulants (from NCDR CathPCI Registry)
Saad M, Tobolski J, Kolte D, Wang Y, Minges K, Hira RS, Curtis JP, Abbott JD. Duration of P2Y12 inhibitor Prescription After Percutaneous Coronary Intervention in Patients on Oral Anticoagulants (from NCDR CathPCI Registry). The American Journal Of Cardiology 2020, 133: 182-184. PMID: 32819682, DOI: 10.1016/j.amjcard.2020.07.029.Peer-Reviewed Original Research
2019
Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates
Chui PW, Wang Y, Ranasinghe I, Mitiku TY, Seto AH, Rosman L, Lampert R, Minges KE, Enriquez AD, Curtis JP. Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates. Circulation Cardiovascular Quality And Outcomes 2019, 12: e005374. PMID: 31185734, PMCID: PMC7412734, DOI: 10.1161/circoutcomes.118.005374.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overClinical CompetenceDefibrillators, ImplantableElectric CountershockFee-for-Service PlansFemaleHumansIncidenceMaleMedicarePostoperative ComplicationsPractice Patterns, Physicians'RegistriesReoperationRisk AssessmentRisk FactorsSpecializationTime FactorsTreatment OutcomeUnited StatesConceptsLong-term device-related complicationsDevice-related complicationsICD implantationLong-term outcomesPhysician specialtyGeneral cardiologistsThoracic surgeonsHigh riskNational Cardiovascular Data Registry ICD RegistryLong-term adverse outcomesImplantable cardioverter defibrillator implantationPhysician specialty trainingCardioverter-defibrillator implantationCumulative incidence rateCase-mix adjusted ratesReoperation rateBackground PatientsConclusions PatientsICD RegistryPrimary outcomeAdverse outcomesIncidence rateInterventional cardiologistsAdjusted ratesReoperation
2018
Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015
Desai NR, Bourdillon PM, Parzynski CS, Brindis RG, Spatz ES, Masters C, Minges KE, Peterson P, Masoudi FA, Oetgen WJ, Buxton A, Zipes DP, Curtis JP. Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015. JAMA 2018, 320: 63-71. PMID: 29971398, PMCID: PMC6583049, DOI: 10.1001/jama.2018.8151.Peer-Reviewed Original ResearchConceptsPrimary prevention ICDsNon-Medicare beneficiariesAbsolute decreaseNational Cardiovascular Data Registry ICD RegistrySerial cross-sectional analysisStudy periodImplantable cardioverter defibrillatorRelative decreaseCross-sectional analysisProportion of devicesInitial ICDICD RegistryPrimary preventionCardioverter defibrillatorMAIN OUTCOMEMedicare beneficiariesUS hospitalsHospital groupHospitalICDMore rapid decreasesModest decreaseDepartmentMedicareUS Department